東誠藥業(002675.SZ):碘[125I]密封籽源新增規格(長度4.5mm×外徑0.60mm)獲批上市
格隆匯11月7日丨東誠藥業(002675.SZ)公佈,近日,公司收到控股子公司上海欣科醫藥有限公司的通知,通知其收到國家藥品監督管理局下發的《藥品補充申請批准通知書》,碘[125I]密封籽源新增規格(長度4.5mm*外徑0.60mm)獲批上市。
碘[125I]密封籽源新增規格(長度4.5mm×外徑0.60mm)獲批上市,將為患者的治療提供更加精準的產品選擇,碘[125I]密封籽源已進入國家醫保乙類目錄,適應症為對於淺表、胸腹腔內的腫瘤(如頭頸部腫瘤、肺癌、胰腺癌、早期前列腺癌),如果其腫瘤為不能切除的、局部的、生長緩慢的、對放射線低度或中度敏感時,可用碘[125I]密封籽源進行治療。碘[125I]密封籽源也可適用於經放射線外照射治療殘留的腫瘤以及復發的腫瘤。主要機理為:碘[125I]密封籽源可長期、間歇地作用於不可切除、未浸潤、生長速率慢而對低、中度放射線敏感的腫瘤,通過射線殺傷植入周圍的腫瘤細胞。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.